Pediatric patients with COVID-19 show better outcomes, shorter hospital stays and produce less antibodies against the infection, shows a recent study that compared children and adults diagnosed with COVID-19.

TOP INSIGHT
COVID-19 has caused more than 29 million cases and 929,000 deaths globally, and high hospitalization rates from the disease have overwhelmed healthcare systems in many cities.
Carl Pierce and colleagues compared data from 65 children and youths (under 24 years of age) and 60 adults hospitalized with COVID-19 in metropolitan New York.
Clinicians say that children and young people have milder symptoms and rarely progress to life-threatening respiratory complications when compared to older people, the opposite of what has been observed with other viral infections such as respiratory syncytial virus.
The infected children including those who had the emerging complication known as multisystem inflammatory syndrome were less prone to require mechanical ventilation and had lower mortality than the adults.
The adults showed higher antibody production and T cell responses to the viral spike protein but lower amounts of inflammatory molecules like IL-17A and IFNγ that are involved in innate immunity.
MEDINDIA


Email









